Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Clearmind Medicine Inc (CMND)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Clearmind Medicine's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.990 -0.010    -1.00%
20:59:59 - Closed. Currency in USD
After Hours
1.020
+0.030
+3.030%
21:21:54 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 58,641
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.956 - 1.020
Clearmind Medicine 0.990 -0.010 -1.00%

Clearmind Medicine Inc Company Profile

 
Get an in-depth profile of Clearmind Medicine Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada.

Contact Information

Address 1220 West 6th Avenue Suite 101
Vancouver, V6H 1A5
Canada
Phone 973 536 1016
Fax -

Top Executives

Name Age Since Title
Alan Mark Rootenberg 71 2020 CFO & Director
Gabriele Fischer - 2021 Member of Scientific Advisory Board
Wim van den Brink - 2021 Member of Scientific Advisory Board
Amitai Weiss 63 2019 Independent Chairman
Michael Davidson 75 - Member of Scientific Advisory Board
Gal Yadid - - Member of Scientific Advisory Board
Joseph Tam - 2023 Member of Scientific Advisory Board
Hila Kiron-Revach 52 2024 Independent Director
Fatima Cody Stanford - 2023 Member of Scientific Advisory Board
Christian G. Schutz - 2022 Member of Scientific Advisory Board
John H. Krystal - 2022 Member of Scientific Advisory Board
Oz Adler 38 2021 Independent Director
Yehonatan Shachar 33 2020 Independent Director
Asaf Itzhaik 52 2022 Independent Director
Mark Haden 70 2021 Vice President of Business Development
Henry R. Kranzler - 2023 Member of Scientific Advisory Board
Alon Friedman - - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CMND Comments

Write your thoughts about Clearmind Medicine Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email